| 
January 17, 2008:
TyRx Pharma, Inc. Announces Food and Drug Administration (FDA) 510(k) Clearance of the AIGISRX™ Cardiac Rhythm Medical Device (CRMD) Anti-Bacterial Envelope, an Innovative Mesh Envelope Designed to Immobilize and Reduce Bacterial Infection of a Pacemaker or Implantable Cardioverter Defibrillator (ICD) When Implanted in the Body (pdf)
December 11 , 2007:
TyRx Pharma, Inc., Announces the Appointment of
Robert M. (Bob) Mattioli as Vice President, Commercial Development (pdf)
October 24, 2007:
TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD (pdf)
August 9, 2007:
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President,
Clinical and Regulatory Affairs (pdf)
March 19, 2007:
TyRx Pharma, Inc. Announces Presentation of the Results of an In-Vivo Efficacy Study Regarding PIVIT™ CRM at the Heart Rhythm Society Meeting (pdf)
February 26, 2007:
TyRx Pharma, Inc., and JFC Technologies Signs Manufacturing Supply Agreement (pdf)
January 29, 2007:
TyRx Pharma, Inc. Announces Strategic Alliance (pdf)
October 16, 2006:
TyRx Pharma, Inc. Announces Submission of a Premarket Application for PIVIT™ CRM, an Innovative Mesh Pouch Designed To Hold and Reduce Bacterial Colonization of a Pacemaker or Implantable Defibrillator Pulse Generator (ICD) When Implanted In the Body (pdf)
July 24, 2006:
TyRx Pharma, Inc., Announces FDA Clearance of PIVIT™ AB, a Novel Antimicrobial-
Coated Surgical Mesh (pdf)
June 20, 2006:
TyRx Pharma, Inc., and Forrest T. Smith, PhD, Awarded the 2006 Fruchaud Prize for Best Scientific Poster Presentation during the 3rd International Hernia Congress (pdf)
May 15, 2006:
TyRx Pharma, Inc., Announces the Election of Dr. Mason Diamond as Industry Representative to the FDA Advisory Committee on Dental Products (pdf)
March 2006:
TyRx Pharma Inc. - Start-ups Across healthcare (pdf)
February 27, 2006:
Physicians Weekly/Bioresorbable Polymer Surgical Mesh (pdf)
January 30, 2006:
TyRx Pharma, Inc., Announces the Signing of Exclusive License Agreement with
Baylor College of Medicine and The University of Texas M. D. Anderson Cancer
Center (pdf)
January 23, 2006:
TyRx Says Combination Products Offer Greater Opportunity than Drug Delivery (pdf)
January 17, 2006:
TyRx Announces FDA 510(K) Filling For New Antibiotic
Eluting Surgical Mesh (pdf)
January 09, 2006:
TyRx Pharma’s Anesthetic Coated Surgical Mesh Combination Product Assigned
to “Device” Center at FDA (pdf)
January 03, 2006:
TyRx Announces FDA 510(k) Clearance for New Surgical Mesh (pdf)
November 07, 2005:
TyRx Pharma, Inc. Joins the Combination Products Coalition (pdf)
October 17, 2005:
TyRx Announces FDA 510(k) Filing for New Surgical Mesh (pdf)
May 09, 2005:
TyRx Pharma, Inc. Announces Two Senior Staff
Additions (pdf)
April 20, 2005: TyRx Pharma,
Inc. Announces Appointments to Its Board of Directors (pdf)
February 2005:
Interview with Bill Edelman, CEO, on Wall Street Reporter.
(mp3 audio file, 4.5MB)
January 31, 2005:
TyRx Pharma, Inc. Announces Equity Investment by Boston
Scientific Corporation (pdf)
|